Prescribing in a Post-Waiver World: Expanding Access to MOUD & Implications of 42 CFR Part 8 Rev.

This webinar provides attendees with strategies for expanding access to medications for opioid use disorder (MOUD) following the elimination of the DATA Waiver (X-waiver), as well as providing a history of the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act and discussing revisions to 42 CFR Part 8. The webinar includes an overview of the SUPPORT Act, enacted in 2018, covering a broad array of actions aimed at addressing the opioid crisis through prevention, treatment, and recovery. The webinar also addresses the revised 42 CFR Part 8 regulations and the historic steps to increase access to lifesaving, evidence-based care through patient-centered and compassionate interventions. Additionally, a panel discussion addresses the integral role physician associates (PAs) and advanced practice registered nurses (APRN) play in expanding access to treatment including strategies for single state agencies on how to increase their PA and APRN provider network.